©The Author(s) 2024.
World J Gastroenterol. Sep 14, 2024; 30(34): 3883-3893
Published online Sep 14, 2024. doi: 10.3748/wjg.v30.i34.3883
Published online Sep 14, 2024. doi: 10.3748/wjg.v30.i34.3883
Table 2 Co-morbidities of patients with erosive esophagitis at Tikur Anbesa specialized hospital and Adera medical and surgical center during the study period
| Co-morbidities | Number (n) | Percentage (%) |
| Diabetes mellitus | 15/221 | 6.8 |
| HTN | 28/221 | 12.7 |
| NAFLD | 7/221 | 3.2 |
| Dyslipidemia | 13/221 | 5.9 |
| CLD/PHTN | 14/221 | 6.3 |
| Asthma | 4/221 | 1.8 |
| IBS | 20/221 | 9 |
| Cholelithiasis | 7/221 | 3.2 |
| Scleroderma | 3/221 | 1.4 |
| Laryngopharyngeal Reflux | 15/221 | 6.8 |
- Citation: Mengistie FA, Shewaye AB, Tasamma AT, Ayalew ZS. Clinical features of gastroesophageal reflux disease and erosive esophagitis: Insights from patients undergoing esophagogastroduodenoscopy in resource-limited Ethiopia. World J Gastroenterol 2024; 30(34): 3883-3893
- URL: https://www.wjgnet.com/1007-9327/full/v30/i34/3883.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i34.3883